BillionToOne, Inc. Class A Common Stock (BLLN)

Health Care·equity
$98.09
+2.81% today
Prices delayed about 15 minutes · cached page, can be an hour old or more
Market Census Score
30/ 100
Score level
Below average
6 of 6 checks had data

Score for how it compares with the broader market is near the bottom of its range — smart-money score is on the low side, while business numbers score is below the middle.

BLLN scores higher than 30% of the 1,101 tickers we compare it with (Health Care).

As of 9 October 2026, BillionToOne, Inc. Class A Common Stock (BLLN) scores 30 out of 100 on the Market Census six-factor composite, which puts it at the Below average score level. The score is made from six named factors: price trend, strength vs the market, company finances, insider trades, market mood and recent momentum. It records what they read on 9 October 2026, and it is not investment advice.

Updated · scores usually change about once a day

TrendStrengthFinancialsInsidersMarketMomentum30/ 100

Key statistics

Market fields as reported. An em-dash means we hold no value for this ticker — most of the universe has no daily price or volume read.

Relative volume
0.53× 30-day average
52-week range
—
Market cap
$5.00B
Earnings date
7 Dec 2026
Volume
325,044
Avg. volume (30d)
611,929
Open
94.46
Previous close
95.41
Day's range (regular session)
94.46 – 100.31

The last trade can be an extended-hours trade, so it can sit outside the regular-session range.

Shown without a peer ranking — we hold no percentile for these yet, so there is nothing here to locate them against.

Beta
0.22
P/E (TTM)
119.38
EPS (TTM)
0.77

Score breakdown · six named factors

Price trend
50
Strength vs the market
1
Company finances
23
Insider trades
13
Market mood
50
Recent momentum
46

Each bar is one part of the score, from 0 to 100. Read what the score means.

Premium data held for BLLN

  • 139 SEC Form 4 insider transactions in the last 90 daysPremium

Counts of rows Market Census holds for BLLN. A dash in the factor table above means that factor has no data for this ticker — it is not a locked value. Compare plans

What the score says about BLLN right now

BillionToOne, Inc. Class A Common Stock (BLLN) currently scores 30/100 on the Market Census six-factor composite, at the Below average score level. BLLN is +2.81% on the day and -6.87% over five sessions as of the most recent tick. Below average sits a bit below the middle. More of BLLN's data reads poorly than well. The level is a "look before you act" flag. It is not advice. BLLN's strongest factor is price trend at 50/100 — a fairly good read on which way the price has been going. The weakest factor is strength vs the market at 1/100 — well below average next to the wider market.

Generated from the six-factor breakdown above. Changes when the underlying scores do, usually about once a day. More on what the score means.

See BLLN in the scanner

This page is free to read with no account at all. Signing up takes an email and a password: a free account runs the scanner on the top 10 scored rows of any scan, keeps one saved screen, a 5-ticker watchlist, and opens 12 ticker detail pages a day. The card is what starts a 30-day Premium trial — $0 that day, then $19.99/month from day 30, cancel online any time before then — and that is what turns on every matching row instead of the first 10, alerts, the 200-ticker watchlist and recent insider buys (SEC Form 4).

Recent BLLN news

Latest headlines that name BillionToOne, one per story, sourced from Market Census’s news feed (Polygon/Massive + Finnhub).

We hide 4 more that told readers to buy or sell, or gave a price target.

Saved snapshot; the news and prices on this page can be an hour old or more.

Similar setups in Health Care right now

Six health care tickers whose composite scores are closest to BLLN’s 30, all within 1 point.

Sorted by closeness to BLLN’s composite score within Health Care. Saved snapshot; can be an hour old or more. Run the full scanner →

Prices delayed about 15 minutes; scores usually change about once a day. Not investment advice — see risk disclosure.